DRTSW · Alpha Tau Medical Ltd. · Documents
Market Cap
$1.25B
Shares
92.48M
Volume · Oct 21
16.22K
Avg daily vol (3M)
42.9K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Alpha Tau Medical Ltd. announced FDA approval to expand its U.S. REGAIN trial of Alpha DaRT for recurrent glioblastoma from 10 to 20 patients, with new endpoints and an interim analysis, and that data will be presented at the SNO 2026 Annual Meeting on November 13. | 2026-10-19 | — | |
| Investor Event Transcript | At an October 15, 2026 DRTS conference, Alpha Tau Medical discussed AlphaDart treatment of three recurrent GBM patients, with two complete responses and one 30% reduction, no unanticipated high-grade CNS toxicities, and a pending FDA request to add seven more patients. | 2026-10-15 | 2026-12-31 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 6-K | — | 2026-08-31 | — | |
| 6-K | — | 2026-08-10 | 2026-06-30 | |
| 6-K | — | 2026-08-10 | — | |
| 6-K | — | 2026-07-21 | — | |
| 6-K | — | 2026-07-15 | — | |
| 6-K | — | 2026-06-25 | — | |
| 6-K | — | 2026-06-23 | — | |
| 6-K | — | 2026-06-11 | — | |
| 6-K | — | 2026-06-03 | — | |
| 6-K | — | 2026-06-01 | — | |
| 6-K | — | 2026-05-18 | — | |
| 6-K | — | 2026-05-18 | — | |
| 6-K | — | 2026-05-11 | — | |
| 6-K | — | 2026-05-11 | — | |
| 6-K | — | 2026-05-08 | — | |
| 6-K | — | 2026-05-08 | — | |
| 6-K | — | 2026-05-07 | — | |
| 6-K | — | 2026-05-05 | — | |
| 6-K | — | 2026-05-04 | — | |
| F-3 | — | 2026-04-28 | — | |
| 6-K | — | 2026-04-27 | — | |
| 6-K | — | 2026-04-23 | — | |
| 6-K | — | 2026-03-31 | — | |
| 6-K | — | 2026-03-09 | — | |
| 20-F | — | 2026-03-09 | 2025-12-31 | |
| 6-K | — | 2026-02-24 | — | |
| 6-K | — | 2026-01-29 | — | |
| 6-K | — | 2026-01-06 | — | |
| 6-K | — | 2026-01-05 | — | |
| 6-K | — | 2025-12-18 | — | |
| 6-K | — | 2025-12-09 | — | |
| 6-K | — | 2025-12-04 | — | |
| 6-K | — | 2025-12-02 | — | |
| 6-K | — | 2025-11-20 | — | |
| 6-K | — | 2025-10-21 | — | |
| 6-K | — | 2025-09-02 | — | |
| 6-K | — | 2025-08-27 | — | |
| 6-K | — | 2025-08-11 | 2025-06-30 | |
| F-3 | — | 2025-06-23 | — | |
| 6-K | — | 2025-06-17 | — | |
| 6-K | — | 2025-05-28 | — | |
| 6-K | — | 2025-05-19 | — | |
| 6-K | — | 2025-05-13 | — | |
| 6-K | — | 2025-05-12 | — | |
| 6-K | — | 2025-05-06 | — | |
| 6-K | — | 2025-04-28 | — | |
| 6-K | — | 2025-04-02 | — |
Showing 1–50 of 141 filings